1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 527 F.Supp.3d
  5. 527 F.Supp.3d 269 (2021)
 

IN RE RESTASIS ANTITRUST LITIGATION

18-MD-2819 (NG) (LB).

527 F.Supp.3d 269 (2021)

IN RE RESTASIS (CYCLOSPORINE OPHTHALMIC EMULSION) ANTITRUST LITIGATION. This Document Applies to: All Endpayor Plaintiff Class Cases.

United States District Court, E.D. New York.

Signed March 15, 2021.

OPINION AND ORDER

In this class action, end-payor plaintiffs ("EPPs") have moved under Federal Rule of Civil Procedure 23(c)(2)(B) for an order approving the proposed form and manner of notice of the certification of the endpayor class and appointing...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases